Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Loading...
Loading...
Score 8.8 from GitHub Security Advisory (severity: HIGH) published 2022-05-14. NVD baseline CVSS 8.8; sources differ by 0.0.
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
March 23, 2019
November 21, 2024
MITRE Common Weakness Enumeration — the root-cause categories this CVE belongs to.
Every time one of our enrichment pipelines (NVD, MITRE cvelistV5, EPSS, CISA KEV, GHSA, OSV, vendor advisories) ran against this CVE. Most recent first.
See which npm, PyPI, Go, and Maven packages are affected by CVE-2015-3965
EchelonGraph automatically scans your cloud infrastructure and maps CVE exposure using blast radius analysis.
CWE-264